Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Lucid Diagnostics Inc. (LUCD)

Lucid Diagnostics receives Nasdaq bid price deficiency notice; stock still trades as LUCD

Negative Impact 3 of 5 legal/regulatory Written later

Lucid Diagnostics received a Nasdaq notice on October 12, 2026, saying its common stock closed below the $1 minimum bid price for 30 consecutive business days through October 9, 2026. The company has until April 12, 2027 to regain compliance, and Nasdaq says the listing is not affected at this time, so shareholders can keep trading the stock under LUCD.

Key points

  • Nasdaq notice dated October 12, 2026 cites a closing bid price below $1 for 30 consecutive business days through October 9, 2026
  • Compliance period runs 180 calendar days, until April 12, 2027, and requires at least $1 for ten consecutive business days
  • Nasdaq says the notice has no effect on the listing now; common stock continues to trade as LUCD

The filing

CompanyLucid Diagnostics Inc. (LUCD)
Form8-K, current report
Filed with the SECOct 16, 2026, 4:30 PM ET
Accession number0001493152-26-047404

Items reported: 3.01 Delisting / Listing Rule Notice

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.